Abstract
It is possible to achieve better results after liver transplantation in adult and pediatric patients. An approach driven by multidisciplinary protocol is the most important factor, along with excellent communication skills, technical expertise, application of new technologies such as MARS and Arctic-Sun for ALF, and new knowledge/treatment protocols such as escalating-dose interferon ribavirin treatment, protocol biopsies, routine use of IL28B gene mutation and new protease inhibitors as part of antiviral therapy for hepatitis C.
MeSH terms
-
Adolescent
-
Adult
-
Child
-
Child, Preschool
-
Connecticut
-
Female
-
Graft Rejection / immunology
-
Graft Rejection / prevention & control
-
Graft Survival
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Infant
-
Liver Diseases / etiology
-
Liver Diseases / surgery*
-
Liver Transplantation* / adverse effects
-
Liver Transplantation* / immunology
-
Liver Transplantation* / mortality
-
Living Donors / supply & distribution
-
Male
-
Program Evaluation
-
Risk Assessment
-
Risk Factors
-
Survival Analysis
-
Time Factors
-
Tissue Donors / supply & distribution*
-
Tissue and Organ Procurement
-
Treatment Outcome